Claritev Accounts Payable

Claritev (CTEV) currently reports a accounts payable of $59M as of March 2026. That compares with $35M in the prior-year period — up 71.5% year over year. Use the charts on this page to explore Claritev's accounts payable history and peer comparisons.

Claritev's accounts payable increased from $35M to $59M — a 71.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Claritev reported $59M in accounts payable as of March 2026. That compares with $35M in the prior-year period — up 71.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $59M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Claritev, and consider following CTEV for alerts when major investors trade the stock.

Claritev is classified in the Healthcare sector. On accounts payable, it currently shows $59M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CTEV with unrelated industries.